Looking for new antifungal drugs from flavonoids: impact of the genetic diversity of Candida albicans on the in-vitro response

Maria Rosa Felice, Letterio Giuffre, Lamya El Aamri, Majida Hafidi, Giuseppe Criseo, Orazio Romeo, Fabio Scordino

Research output: Contribution to journalArticle

Abstract

In an era in which antimicrobial resistance is increasing at an alarming pace, it's very important to find new antimicrobial agents effective against pathogenic microrganisms resistant to traditional treatments. Among the notable breakthroughs in the past years of research in natural-drug discovery there is the identification and testing of flavonoids, a group of plant-derived substances capable of promoting many beneficial effects on humans. These compounds show different biological activities such as inhibition of neuroinflammation and tumor growth as well as antidepressant, antiarthritic, anti-hypercholesterolemic, antidiabetic, antiulcer and antiasthmatic activities. However, one of the most important effects of these phytochemicals is, undoubtedly, their antimicrobial activity against many microbial pathogens. In recent years, hundreds of scientific papers reported the inhibitory effects of flavonoids against pathogenic fungi but none of these has ever considered the inexorable genetic changes occurring within the populations of these microrganisms. Today, we have enough information to estimate genetic diversity within microbial species and recent data revealed that most of fungal pathogens shows a complex population structure in which no a single isolate can be designate as representative of the entire taxon. This is especially true for the highly divergent fungal pathogen Candida albicans, in which the assumption that one or few "standard strains" can represent the whole species is overly unrealistic and should be laid to rest. The goal of this article is to shed light on the extent of genetic variation in C. albicans and how this phenomenon can largely influence the activity of flavonoids against this species.

Original languageEnglish
JournalCurrent Medicinal Chemistry
DOIs
Publication statusE-pub ahead of print - Dec 25 2017

Fingerprint

Candida
Pathogens
Candida albicans
Flavonoids
Pharmaceutical Preparations
Anti-Asthmatic Agents
Phytochemicals
Drug Discovery
Anti-Infective Agents
Bioactivity
Fungi
Hypoglycemic Agents
Antidepressive Agents
Population
Tumors
Testing
Growth
Research
In Vitro Techniques
Neoplasms

Keywords

  • Journal Article

Cite this

Looking for new antifungal drugs from flavonoids: impact of the genetic diversity of Candida albicans on the in-vitro response. / Felice, Maria Rosa; Giuffre, Letterio; El Aamri, Lamya; Hafidi, Majida; Criseo, Giuseppe; Romeo, Orazio; Scordino, Fabio.

In: Current Medicinal Chemistry, 25.12.2017.

Research output: Contribution to journalArticle

Felice, Maria Rosa ; Giuffre, Letterio ; El Aamri, Lamya ; Hafidi, Majida ; Criseo, Giuseppe ; Romeo, Orazio ; Scordino, Fabio. / Looking for new antifungal drugs from flavonoids: impact of the genetic diversity of Candida albicans on the in-vitro response. In: Current Medicinal Chemistry. 2017.
@article{562a8f19d3754c82aec38c9ea1449ee7,
title = "Looking for new antifungal drugs from flavonoids: impact of the genetic diversity of Candida albicans on the in-vitro response",
abstract = "In an era in which antimicrobial resistance is increasing at an alarming pace, it's very important to find new antimicrobial agents effective against pathogenic microrganisms resistant to traditional treatments. Among the notable breakthroughs in the past years of research in natural-drug discovery there is the identification and testing of flavonoids, a group of plant-derived substances capable of promoting many beneficial effects on humans. These compounds show different biological activities such as inhibition of neuroinflammation and tumor growth as well as antidepressant, antiarthritic, anti-hypercholesterolemic, antidiabetic, antiulcer and antiasthmatic activities. However, one of the most important effects of these phytochemicals is, undoubtedly, their antimicrobial activity against many microbial pathogens. In recent years, hundreds of scientific papers reported the inhibitory effects of flavonoids against pathogenic fungi but none of these has ever considered the inexorable genetic changes occurring within the populations of these microrganisms. Today, we have enough information to estimate genetic diversity within microbial species and recent data revealed that most of fungal pathogens shows a complex population structure in which no a single isolate can be designate as representative of the entire taxon. This is especially true for the highly divergent fungal pathogen Candida albicans, in which the assumption that one or few {"}standard strains{"} can represent the whole species is overly unrealistic and should be laid to rest. The goal of this article is to shed light on the extent of genetic variation in C. albicans and how this phenomenon can largely influence the activity of flavonoids against this species.",
keywords = "Journal Article",
author = "Felice, {Maria Rosa} and Letterio Giuffre and {El Aamri}, Lamya and Majida Hafidi and Giuseppe Criseo and Orazio Romeo and Fabio Scordino",
note = "Copyright{\circledC} Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.",
year = "2017",
month = "12",
day = "25",
doi = "10.2174/0929867325666171226102700",
language = "English",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Looking for new antifungal drugs from flavonoids: impact of the genetic diversity of Candida albicans on the in-vitro response

AU - Felice, Maria Rosa

AU - Giuffre, Letterio

AU - El Aamri, Lamya

AU - Hafidi, Majida

AU - Criseo, Giuseppe

AU - Romeo, Orazio

AU - Scordino, Fabio

N1 - Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

PY - 2017/12/25

Y1 - 2017/12/25

N2 - In an era in which antimicrobial resistance is increasing at an alarming pace, it's very important to find new antimicrobial agents effective against pathogenic microrganisms resistant to traditional treatments. Among the notable breakthroughs in the past years of research in natural-drug discovery there is the identification and testing of flavonoids, a group of plant-derived substances capable of promoting many beneficial effects on humans. These compounds show different biological activities such as inhibition of neuroinflammation and tumor growth as well as antidepressant, antiarthritic, anti-hypercholesterolemic, antidiabetic, antiulcer and antiasthmatic activities. However, one of the most important effects of these phytochemicals is, undoubtedly, their antimicrobial activity against many microbial pathogens. In recent years, hundreds of scientific papers reported the inhibitory effects of flavonoids against pathogenic fungi but none of these has ever considered the inexorable genetic changes occurring within the populations of these microrganisms. Today, we have enough information to estimate genetic diversity within microbial species and recent data revealed that most of fungal pathogens shows a complex population structure in which no a single isolate can be designate as representative of the entire taxon. This is especially true for the highly divergent fungal pathogen Candida albicans, in which the assumption that one or few "standard strains" can represent the whole species is overly unrealistic and should be laid to rest. The goal of this article is to shed light on the extent of genetic variation in C. albicans and how this phenomenon can largely influence the activity of flavonoids against this species.

AB - In an era in which antimicrobial resistance is increasing at an alarming pace, it's very important to find new antimicrobial agents effective against pathogenic microrganisms resistant to traditional treatments. Among the notable breakthroughs in the past years of research in natural-drug discovery there is the identification and testing of flavonoids, a group of plant-derived substances capable of promoting many beneficial effects on humans. These compounds show different biological activities such as inhibition of neuroinflammation and tumor growth as well as antidepressant, antiarthritic, anti-hypercholesterolemic, antidiabetic, antiulcer and antiasthmatic activities. However, one of the most important effects of these phytochemicals is, undoubtedly, their antimicrobial activity against many microbial pathogens. In recent years, hundreds of scientific papers reported the inhibitory effects of flavonoids against pathogenic fungi but none of these has ever considered the inexorable genetic changes occurring within the populations of these microrganisms. Today, we have enough information to estimate genetic diversity within microbial species and recent data revealed that most of fungal pathogens shows a complex population structure in which no a single isolate can be designate as representative of the entire taxon. This is especially true for the highly divergent fungal pathogen Candida albicans, in which the assumption that one or few "standard strains" can represent the whole species is overly unrealistic and should be laid to rest. The goal of this article is to shed light on the extent of genetic variation in C. albicans and how this phenomenon can largely influence the activity of flavonoids against this species.

KW - Journal Article

U2 - 10.2174/0929867325666171226102700

DO - 10.2174/0929867325666171226102700

M3 - Article

C2 - 29278204

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

ER -